High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Published:2016-08 Issue: Volume:16 Page:S30-S38
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Han Xin,Medeiros L. Jeffrey,Zhang Yu Helen,You M. James,Andreeff Michael,Konopleva Marina,Bueso-Ramos Carlos E.

Funder

Leukemia SPORE

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. Adult acute myeloid leukemia;Jabbour;Mayo Clin Proc,2006

2. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

3. MDM2, an introduction;Iwakuma;Mol Cancer Res,2003

4. MDMX: a novel p53-binding protein with some functional properties of MDM2;Shvarts;EMBO J,1996

5. Mdmx as an essential regulator of p53 activity;Marine;Biochem Biophys Res Commun,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignancies;Cancer Medicine;2024-07

2. p53 biology and reactivation for improved therapy in MDS and AML;Biomarker Research;2024-03-13

3. Cellular carcinogenesis in preleukemic conditions:drivers and defenses;FUKUSHIMA JOURNAL OF MEDICAL SCIENCE;2024

4. Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies;Experimental Hematology;2023-06

5. Reduced murine double minute 2 and 4 protein, but not messenger RNA , expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia;British Journal of Haematology;2022-12-22